Drugs / Hyruan-One
last change Dec 2023 re-read 2 minutes ago

Hyruan-One

Developed for
osteoarthritis, knee
Investigated by
Thammasat University

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03484091 Apr 2018 → Jun 2023 osteoarthritis, knee Thammasat University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hyruan-One ClinicalTrials.gov intervention name — accepted as the source's own label NCT03484091
Route Other “intra-articular knee injection” NCT03484091